Cannabis Bioscience International Holdings, Inc. (CBIH)

Revenue by Segment

Financials in millions USD. Fiscal year is June - May.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020
Healthcare Facilities & Services	303.02K	248.84K	316.83K	214.98K	761.74K
Healthcare Facilities & Services Growth	21.77%	-21.46%	47.37%	-71.78%	162.46%
Total	303.02K	248.84K	316.83K	214.98K	761.74K
Total Growth	21.77%	-21.46%	47.37%	-71.78%	162.46%

Revenue by Geography

Financials in millions USD. Fiscal year is June - May.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020
United States	303.02K	248.84K	316.83K	214.98K	761.74K
United States Growth	21.77%	-21.46%	47.37%	-71.78%	162.46%
Total	303.02K	248.84K	316.83K	214.98K	761.74K
Total Growth	21.77%	-21.46%	47.37%	-71.78%	162.46%

Data Source: S&P Global Market Intelligence Last updated: Feb 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 16, 2026

Data Sources Report a data error